TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Marksans Pharma Limited ( (IN:MARKSANS) ) just unveiled an announcement.
Marksans Pharma Limited has announced the appointment of M/s Jinesh Dedhia & Associates as the Secretarial Auditor for a five-year term starting from April 1, 2025, to March 31, 2030. This strategic move is part of the company’s compliance with regulatory requirements and aims to enhance its governance practices, potentially strengthening its market position and stakeholder confidence.
More about Marksans Pharma Limited
Marksans Pharma Limited is a company operating in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical products. The company serves various markets, including domestic and international sectors, with a range of therapeutic products.
Average Trading Volume: 100,455
Current Market Cap: 117.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.